Sergio Traversa
Board Member
Relmada Therapeutics, Inc. (RLMD)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Sergio Traversa
Sergio Traversa is recorded as CEO and Board Member at Relmada Therapeutics, Inc. (RLMD). Relmada Therapeutics, Inc. reported in an 8-K filed May 25, 2023 that Sergio Traversa was appointed Class II Director, effective May 25, 2023. Sergio Traversa has spoken on 21 earnings calls and 1 other investor event across 1 company, most recently for Relmada Therapeutics, Inc. on June 4, 2026.
“Stockholders elected the following nominees as directors to hold office until the 2026 Annual Meeting (i.e. as a Class II Director) and until his successor is elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Relmada Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Charles J. Casamento Chairman, Board Member
- Maged Shenouda CFO
- Paul Kelly COO, Board Member
- Charles Ence Chief Accounting Officer
- Fabiana Fedeli Board Member
- John Glasspool Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.